Literature DB >> 26587227

Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease.

Eman M Alissa1, Wafa A Alnahdi1, Nabil Alama1, Gordon A Ferns2.   

Abstract

It has been suggested that osteoporosis and coronary artery disease (CAD) have overlapping pathophysiological mechanisms and related risk factors. The aim of this study was to investigate the association between several traditional cardiovascular risk factors and measures of bone mineral density (BMD) in postmenopausal women with and without clinically significant CAD defined angiographically. A case-control study was undertaken of 180 postmenopausal women (aged between 48 and 88 years) who were recruited from King Abdulaziz University Hospital, Saudi Arabia. Study subjects underwent dual-energy x-ray absorptiometry and coronary angiography. The presence of hypertension, diabetes, dyslipidemia, obesity, smoking and physical activity was identified from clinical examination and history. Demographic, anthropometric and biochemical characteristics were measured. Univariate and multivariate analyses were employed to explore the relationships between cardiovascular risk factors, including BMD, and the presence of CAD. CAD patients were more likely to have a lower BMD and T-score at the femoral neck than those without CAD (P<0.05). Significant differences were found between the groups for fasting lipid profile, fasting blood glucose and anthropometric measures (P<0.05). Conditional logistic regression showed that 3 risk factors were significantly related with the presence of CAD: high-density lipoprotein-cholesterol (odds ratio, OR: 0.226, 95% confidence interval, CI: 0.062-0.826), fasting plasma glucose (OR: 1.154, 95% CI: 1.042-1.278) and femoral neck T-score (OR: 0.545, 95% CI: 0.374-0.794). This study suggests an association of low BMD and elevated CAD risk. Nevertheless, additional longitudinal studies are needed to determine the temporal sequence of this association.

Entities:  

Year:  2015        PMID: 26587227      PMCID: PMC4644069          DOI: 10.1038/bonekey.2015.127

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  36 in total

1.  Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001.

Authors:  M R Soules; S Sherman; E Parrott; R Rebar; N Santoro; W Utian; N Woods
Journal:  Menopause       Date:  2001 Nov-Dec       Impact factor: 2.953

Review 2.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

Authors:  Lori Mosca; Carole L Banka; Emelia J Benjamin; Kathy Berra; Cheryl Bushnell; Rowena J Dolor; Theodore G Ganiats; Antoinette S Gomes; Heather L Gornik; Clarissa Gracia; Martha Gulati; Constance K Haan; Debra R Judelson; Nora Keenan; Ellie Kelepouris; Erin D Michos; L Kristin Newby; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Diana Petitti; Vivian W Pinn; Rita F Redberg; Rosalyn Scott; Katherine Sherif; Sidney C Smith; George Sopko; Robin H Steinhorn; Neil J Stone; Kathryn A Taubert; Barbara A Todd; Elaine Urbina; Nanette K Wenger
Journal:  Circulation       Date:  2007-02-19       Impact factor: 29.690

3.  Bone metabolism in type 2 diabetes mellitus.

Authors:  G C Isaia; P Ardissone; M Di Stefano; D Ferrari; V Martina; M Porta; M Tagliabue; G M Molinatti
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

Review 4.  Cholesterol, lipoproteins, and coronary heart disease in women.

Authors:  T L Bush; L P Fried; E Barrett-Connor
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

5.  Cardiovascular mortality and morbidity in type-2 diabetes mellitus.

Authors:  G Schernthaner
Journal:  Diabetes Res Clin Pract       Date:  1996-07       Impact factor: 5.602

Review 6.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 7.  Menopause and cardiovascular disease: the evidence.

Authors:  G M C Rosano; C Vitale; G Marazzi; M Volterrani
Journal:  Climacteric       Date:  2007-02       Impact factor: 3.005

Review 8.  Cardiovascular disease and osteoporosis.

Authors:  V Baldini; M Mastropasqua; C M Francucci; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

9.  Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women.

Authors:  Kyong-Chol Kim; Dong-Hyuk Shin; Sei-Young Lee; Jee-Aee Im; Duk-Chul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

10.  Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus.

Authors:  M Nieuwdorp; M Vergeer; R J Bisoendial; J op 't Roodt; H Levels; R S Birjmohun; J A Kuivenhoven; R Basser; T J Rabelink; J J P Kastelein; E S G Stroes
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

View more
  4 in total

1.  Association between Osteoporosis and Cognitive Impairment during the Acute and Recovery Phases of Ischemic Stroke.

Authors:  Sang-Hwa Lee; So Young Park; Min Uk Jang; Yerim Kim; Jungyoup Lee; Chulho Kim; Yeo Jin Kim; Jong-Hee Sohn
Journal:  Medicina (Kaunas)       Date:  2020-06-23       Impact factor: 2.430

2.  Bone Mineral Density as a Predictor of Atherogenic Indexes of Cardiovascular Disease, Especially in Nonobese Adults.

Authors:  Tzyy-Ling Chuang; Jiunn-Wen Lin; Yuh-Feng Wang
Journal:  Dis Markers       Date:  2019-09-04       Impact factor: 3.434

3.  The link between bone disease and cardiovascular complications in hemodialysis patients.

Authors:  Noha Elsheikh; Nevine Sherif; Sameh Abou Zeid; Mervat Eldamarawy; Ahmed Ali; Amal Ismail Sabry
Journal:  Electron Physician       Date:  2016-06-25

4.  Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study.

Authors:  Wei Gan; Robert J Clarke; Anubha Mahajan; Benard Kulohoma; Hidetoshi Kitajima; Neil R Robertson; N William Rayner; Robin G Walters; Michael V Holmes; Zhengming Chen; Mark I McCarthy
Journal:  Wellcome Open Res       Date:  2017-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.